Invesco International BuyBack Achievers ETF (IPKW)
Live price chart, market sentiment, and community perspectives for Invesco International BuyBack Achievers ETF (NASDAQ: IPKW).
Live price chart, market sentiment, and community perspectives for Invesco International BuyBack Achievers ETF (NASDAQ: IPKW).
On our desk, we are tracking the recent institutional shifts in IPKW closely. With 89 funds holding approximately $352M, the sentiment shows repeat investments outweighing major reductions despite a slight net drop in total holding funds. Market participants appreciate the 3.63% indicated dividend yield and the solid 1-year change of +23.26%, but political and macro sentiment around international bank exposure requires careful monitoring.
Looking at the quantitative risk metrics for IPKW, the fund showcases an impressive 1-year alpha of +13.78 and a Sharpe ratio of 2.59 compared to the MSCI ACWI Ex USA NR USD benchmark. However, our risk management group notes that its high portfolio concentration in financials and elevated turnover introduce systemic vulnerabilities that standard volatility metrics alone fail to capture.
When evaluating IPKW for technical allocation protocols, analysts must factor in its physical replication method tracking the NASDAQ International BuyBack Achievers Index. With an AUM hovering around $509.28M and a modest 0.55% expense ratio, the strategy successfully isolates firms engaging in significant buybacks, but traders should balance these positive screens against its relatively concentrated holding structure.
Watching the short interest data for IPKW as of late June 2026, short volume sits at 9,772 shares, which marks a 42.72% increase month-over-month. Even with this relative jump, the days-to-cover ratio is extremely low at 0.3 based on an average trading volume of 60,125 shares. This indicates minimal aggressive short-selling pressure in the open market.
On our trading desk, liquidity assessment for IPKW shows a steady bid-ask profile with a tiny discount/premium to NAV of -0.3%. The fund trades reliably with a 52-week range between $48.59 and $60.41. Portfolio managers building out international exposure should weigh its historical outperformance against peer group comparisons where foreign large value alternatives may offer better risk-adjusted value.
Explore plasma cleansing, somatic organ swaps, and BCI.